By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

When physicians speak to an overweight child they should inquire carefully about a history of physical, sexual or emotional ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.

In a dramatic new discovery, scientists found that eliminating a single amino acid from the body triggers an extreme energy ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

The opioid epidemic, obesity, federal employee suicide and depression rates, and drug prices are on our readers’ minds.

Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...